Clinical Trial Services — bioaccess®
bioaccess® offers a full suite of clinical trial services for MedTech, Biopharma, and Radiopharma companies conducting studies in Latin America.
Service Offerings
- First-in-Human (FIH) Clinical Trials — end-to-end FIH trial management with 12-month timeline guarantee
- Early Feasibility Studies (EFS) — FDA IDE-ready early feasibility device studies
- Radiopharmaceutical Trials — Lu-177, Ac-225, Ga-68 clinical studies with nuclear medicine infrastructure
- Medical Device Registration — ANVISA, INVIMA, COFEPRIS, ANMAT, ISP, DIGEMID pathways
- Market Access Strategy — Latin American market entry for FDA/CE-cleared devices
- Clinical Trial Site Search & Selection — 50+ pre-qualified sites in 10 countries
- Regulatory Strategy — FDA bridge data, ICH-GCP compliance, 21 CFR 812.28
- FastTrack™ Program — accelerated FIH pathway with guaranteed timelines
Request a Proposal